Bank Of America Corp Atara Biotherapeutics, Inc. Transaction History

Bank Of America Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.44 - $1.22 $2.81 Million - $7.8 Million	6,391,449 Added 3379.43%	6,580,577 $4.54 Million
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $24,791 - $187,556	107,791 Added 132.52%	189,128 $96,000
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $1.7 Million - $3.44 Million	-1,132,963 Reduced 93.3%	81,337 $130,000
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $2.35 Million - $4.57 Million	837,836 Added 222.55%	1,214,300 $3.52 Million
Q4 2022 Feb 10, 2023	SELL	$2.85 - $5.18 $305,397 - $555,073	-107,157 Reduced 22.16%	376,464 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $390,971 - $1.2 Million	137,183 Added 39.6%	483,621 $1.83 Million
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $750,643 - $1.57 Million	160,052 Added 85.87%	346,438 $2.7 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $527,660 - $1.06 Million	62,519 Added 50.47%	186,386 $1.73 Million
Q4 2021 Feb 08, 2022	BUY	$14.7 - $19.89 $921,939 - $1.25 Million	62,717 Added 102.56%	123,867 $1.95 Million
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $262,197 - $391,437	21,868 Added 55.67%	61,150 $1.09 Million
Q2 2021 Sep 13, 2021	BUY	$12.89 - $16.58 $506,344 - $651,295	39,282 New	39,282 $611,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $992M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.